Bristol-Myers CEO Says the Company Is in Transition

[ad_1] Bristol-Myers CEO Says the Company Is in Transition  Bloomberg [ad_2] Source link

Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion

[ad_1] Updated Dec. 26, 2023 12:33 pm ET Drug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology.  RayzeBio…

Lombard Odier Asset Management Switzerland SA Sells 215,121 Shares of Bristol-Myers Squibb (NYSE:BMY)

[ad_1] Lombard Odier Asset Management Switzerland SA cut its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 91.8% in the second quarter, according to the company in…

Bristol-Myers CEO Giovanni Caforio to Step Down

[ad_1] Chief Commercialization Officer Christopher Boerner will take over after Giovanni Caforio retires, the company said. [ad_2] Source link